MAM
Meeder Asset Management Portfolio holdings
AUM
$1.63B
1-Year Return
27.94%
This Quarter Return
-1.02%
1 Year Return
+27.94%
3 Year Return
+116.82%
5 Year Return
+187.4%
10 Year Return
+462.19%
AUM
$1.48B
AUM Growth
+$40.5M
(+2.8%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
7.61%
Top 10 Holdings %
Top 10 Hldgs %
48.04%
Holding
1,081
New
175
Increased
237
Reduced
381
Closed
180
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$68.6M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$45M |
| 3 |
Apple
AAPL
|
$18.6M |
| 4 |
Dover
DOV
|
$17.5M |
| 5 |
Ecolab
ECL
|
$17.3M |
Top Sells
| 1 |
Texas Instruments
TXN
|
$30.6M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$22M |
| 3 |
TJX Companies
TJX
|
$20.3M |
| 4 |
Qualcomm
QCOM
|
$19.4M |
| 5 |
Kimberly-Clark
KMB
|
$17.7M |
Sector Composition
| 1 | Technology | 22% |
| 2 | Financials | 17.84% |
| 3 | Communication Services | 9.35% |
| 4 | Consumer Discretionary | 8.46% |
| 5 | Healthcare | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Exelixis
EXEL
$10.2B
| $2.55K | ﹤0.01% |
+69
| New | +$2.55K |
|
852
SM Energy
SM
$3.09B
| $2.52K | ﹤0.01% |
+84
| New | +$2.52K |
|
853
Element Solutions
ESI
$6.33B
| $2.49K | ﹤0.01% |
110
-78
| -41% | -$1.76K |
|
854
SL Green Realty
SLG
$4.4B
| $2.48K | ﹤0.01% |
43
-15
| -26% | -$865 |
|
855
Zymeworks
ZYME
$1.14B
| $2.45K | ﹤0.01% |
+206
| New | +$2.45K |
|
856
Repligen
RGEN
$7.01B
| $2.42K | ﹤0.01% |
19
-9
| -32% | -$1.15K |
|
857
Masimo
MASI
$8B
| $2.33K | ﹤0.01% |
+14
| New | +$2.33K |
|
858
Moderna
MRNA
$9.78B
| $2.33K | ﹤0.01% |
82
-30
| -27% | -$851 |
|
859
Estee Lauder
EL
$32.1B
| $2.24K | ﹤0.01% |
34
-14
| -29% | -$924 |
|
860
Cushman & Wakefield
CWK
$3.84B
| $2.21K | ﹤0.01% |
216
-18
| -8% | -$184 |
|
861
FMC
FMC
$4.72B
| $2.19K | ﹤0.01% |
52
-23
| -31% | -$970 |
|
862
Olin
OLN
$2.9B
| $2.16K | ﹤0.01% |
+89
| New | +$2.16K |
|
863
Crinetics Pharmaceuticals
CRNX
$3.35B
| $2.15K | ﹤0.01% |
64
-17
| -21% | -$570 |
|
864
Macerich
MAC
$4.74B
| $2.11K | ﹤0.01% |
123
-50
| -29% | -$859 |
|
865
CNX Resources
CNX
$4.18B
| $2.11K | ﹤0.01% |
+67
| New | +$2.11K |
|
866
Cytokinetics
CYTK
$6.34B
| $2.09K | ﹤0.01% |
52
-24
| -32% | -$965 |
|
|
CNR
867
Core Natural Resources, Inc.
CNR
$3.89B
| $2.01K | ﹤0.01% |
26
-5,466
| -100% | -$422K |
|
868
Kymera Therapeutics
KYMR
$3.11B
| $1.97K | ﹤0.01% |
+72
| New | +$1.97K |
|
869
Cleveland-Cliffs
CLF
$5.63B
| $1.91K | ﹤0.01% |
232
-136
| -37% | -$1.12K |
|
870
Guardant Health
GH
$7.5B
| $1.87K | ﹤0.01% |
44
-32
| -42% | -$1.36K |
|
871
Bloom Energy
BE
$13.4B
| $1.83K | ﹤0.01% |
93
-29
| -24% | -$570 |
|
872
Exact Sciences
EXAS
$10.2B
| $1.78K | ﹤0.01% |
41
-15
| -27% | -$649 |
|
873
Acumen Pharmaceuticals
ABOS
$87.2M
| $1.74K | ﹤0.01% |
+1,584
| New | +$1.74K |
|
874
Doximity
DOCS
$13B
| $1.68K | ﹤0.01% |
29
-23
| -44% | -$1.34K |
|
875
Coeur Mining
CDE
$9.43B
| $1.68K | ﹤0.01% |
283
-39
| -12% | -$231 |
|